View in EDS

EE57 Healthcare Costs Avoided in the Treatment of Acquired Thrombotic Thrombocytopenic Purpura with Caplacizumab in Colombia.

Saved in:
Bibliographic Details
Title: EE57 Healthcare Costs Avoided in the Treatment of Acquired Thrombotic Thrombocytopenic Purpura with Caplacizumab in Colombia.
Authors: Londono, S.1 (AUTHOR), Gil-Rojas, Y.2 (AUTHOR), Lasalvia, P.2 (AUTHOR)
Source: Value in Health. 2023 Supplement, Vol. 26 Issue 6, pS69-S69. 1p.
Database: Academic Search Ultimate
Description
ISSN:10983015
DOI:10.1016/j.jval.2023.03.362